ArticleNPJ precision oncology2024

Tertiary lymphoid structures potentially promote immune checkpoint inhibitor response in SMARCB1-deficient medullary renal cell carcinoma.

Yanfeng Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.